BPL-1357 Against H1N1 Influenza Virus Challenge

Abroad (travel likely)RecruitingPHASE2

Conditions

Influenza · Human

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222
University of Texas Medical Branch, Galveston, Galveston, Texas, United States
Contact: Study coordinator (Gregory Gray) · gcgray@utmb.edu · 409-772-0633

Study leads

Luca T Giurgea, M.D.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Influenza · Influenza, Human

Abroad (travel likely)RecruitingPHASE2

Minas Gerais, Brazil · Vientiane, Laos

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Dengue · Chikungunya · Zika Virus Infection

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia

Covid-19 and Influenza Oral Vaccine Study

covid19 Infection · Influenza, Human

Abroad (travel likely)RecruitingPHASE1

Adelaide, Australia

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

Influenza, Human

Abroad (travel likely)RecruitingPHASE3

Chizhou, China